Provider
It will focus on creating digital solutions for ophthalmic, neurological and psychiatric disorders.
Only 1.3% of images included in the public data set included patient ethnicity.
Ellume began recalling the tests last month for giving false positive results.
The tool uses information about pain level, condition and current medication regimen to find an effective dose of opioids.
Third-party developers can use the platform to build their own products or update instruments.
The scheme is being run in partnership with government technology firm PUBLIC.
The pair aim to make AI-enhanced diagnostics accessible beyond hospital settings.
The two companies will also collaborate on a clinical study using AI mammography.
HoneyNaps claims its software provides more accurate readings than conventional auto-scoring.
Also, Indian voice AI platform Augnito has introduced its voice AI SaaS during the Diwali.